Department of Cardiovascular Medicine, Toho University Graduate School of Medicine, Japan.
Division of Cardiovascular Medicine, Department of Internal Medicine, Toho University Faculty of Medicine, Japan.
Intern Med. 2022 Feb 15;61(4):501-505. doi: 10.2169/internalmedicine.8731-21. Epub 2021 Nov 27.
COVID-19 vaccine-related myocarditis has been reported worldwide. We herein report two Japanese cases with suspected vaccine-related myocarditis. A 27-year-old man was admitted with chest pain 4 days after the second vaccination. An electrocardiogram (ECG) did not reveal any significant abnormalities. The second patient, a 37-year-old man, was admitted with chest pain 9 days after the first vaccination. His ECG exhibited ST-elevation in multiple leads. In both cases, cardiac magnetic resonance imaging findings were consistent with myocarditis. They recovered with symptomatic relief within a few days. These cases suggest that the benefit of COVID-19 vaccination exceeds the risk of vaccine-related myocarditis.
COVID-19 疫苗相关心肌炎已在全球范围内报告。我们在此报告两例日本疑似疫苗相关心肌炎病例。一名 27 岁男性在第二次接种后 4 天因胸痛入院。心电图(ECG)未显示任何明显异常。第二例患者为 37 岁男性,在第一次接种后 9 天因胸痛入院。他的心电图多个导联出现 ST 段抬高。在这两例病例中,心脏磁共振成像结果均符合心肌炎。他们在数天内通过对症治疗得到缓解并康复。这些病例表明 COVID-19 疫苗接种的益处超过了疫苗相关心肌炎的风险。